Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000760811 | SCV000890706 | pathogenic | not provided | 2024-02-15 | criteria provided, single submitter | clinical testing | Reported in a patient with Kabuki syndrome (PMID: 36891680); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 36891680) |
Laboratory of Molecular Genetics |
RCV001779074 | SCV002016262 | pathogenic | Neurodevelopmental disorder | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003642916 | SCV004381907 | pathogenic | Kabuki syndrome 2 | 2023-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg658*) in the KDM6A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KDM6A are known to be pathogenic (PMID: 23076834, 23913813). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KDM6A-related conditions. ClinVar contains an entry for this variant (Variation ID: 620434). For these reasons, this variant has been classified as Pathogenic. |